NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27604143)

Published in Sci Rep on September 08, 2016

Authors

Verónica García-Carpizo1, Jacinto Sarmentero1, Bomie Han2, Osvaldo Graña3, Sergio Ruiz-Llorente1, David G Pisano3, Manuel Serrano4, Harold B Brooks2, Robert M Campbell2, Maria J Barrero1

Author Affiliations

1: CNIO-Lilly Epigenetics Laboratory, Spanish National Cancer Research Center (CNIO), C/ Melchor Fernández Almagro, 3. 28029 Madrid, Spain.
2: Eli Lilly and Company, 46285 Indianapolis, USA.
3: Structural Biology and Biocomputing Program, Spanish National Cancer Research Center (CNIO), C/ Melchor Fernández Almagro, 3. 28029 Madrid, Spain.
4: Molecular Oncology Program, Spanish National Cancer Research Center (CNIO), C/Melchor Fernández Almagro, 3. 28029 Madrid, Spain.

Articles cited by this

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol (2009) 235.12

The Sequence Alignment/Map format and SAMtools. Bioinformatics (2009) 232.39

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46

NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41

Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc (2012) 35.75

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13

Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature (2012) 18.23

GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol (2010) 16.72

BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell (2011) 14.34

Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature (2008) 10.95

Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell (2013) 9.55

Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell (2013) 8.37

A clustering approach for identification of enriched domains from histone modification ChIP-Seq data. Bioinformatics (2009) 8.33

Super-enhancers in the control of cell identity and disease. Cell (2013) 7.50

Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol (2003) 6.21

Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. EMBO J (2007) 3.81

Chemical derivatization of histones for facilitated analysis by mass spectrometry. Nat Protoc (2007) 3.78

The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. Blood (1998) 3.69

Gene density, transcription, and insulators contribute to the partition of the Drosophila genome into physical domains. Mol Cell (2012) 3.08

The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol Cell Biol (2011) 3.01

BEDTools: The Swiss-Army Tool for Genome Feature Analysis. Curr Protoc Bioinformatics (2014) 2.90

CpG islands recruit a histone H3 lysine 36 demethylase. Mol Cell (2010) 2.86

WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Hum Mol Genet (1998) 2.77

The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. Blood (2010) 2.71

Domains of genome-wide gene expression dysregulation in Down's syndrome. Nature (2014) 2.30

The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901. Bioorg Med Chem Lett (2008) 2.28

The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains. Genes Dev (2015) 2.28

NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming. Mol Cell (2011) 2.27

Localized H3K36 methylation states define histone H4K16 acetylation during transcriptional elongation in Drosophila. EMBO J (2007) 2.19

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci U S A (2013) 2.00

Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Mol Cell (2015) 1.96

Regional activation of the cancer genome by long-range epigenetic remodeling. Cancer Cell (2012) 1.91

Tissue-specific expression and post-translational modification of histone H3 variants. J Proteome Res (2008) 1.84

Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia. Nat Genet (2013) 1.77

The regulatory content of intergenic DNA shapes genome architecture. Genome Biol (2004) 1.70

The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity. Blood (2007) 1.60

PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies. Nature (2014) 1.60

Characteristics of lung cancers harboring NRAS mutations. Clin Cancer Res (2013) 1.41

Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer. Mol Cell (2012) 1.34

An epigenomic approach to therapy for tamoxifen-resistant breast cancer. Cell Res (2014) 1.29

The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors. Clin Cancer Res (2011) 1.26

Cancers and the NSD family of histone lysine methyltransferases. Biochim Biophys Acta (2011) 1.21

MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells. Haematologica (2008) 1.20

Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies. Leukemia (2013) 1.17

A unique mRNA initiated within a middle intron of WHSC1/MMSET encodes a DNA binding protein that suppresses human IL-5 transcription. Am J Respir Cell Mol Biol (2001) 1.17

Total kinetic analysis reveals how combinatorial methylation patterns are established on lysines 27 and 36 of histone H3. Proc Natl Acad Sci U S A (2012) 1.12

Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway. Neoplasia (2011) 1.08

The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer. Oncogene (2012) 1.07

Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop. Mol Cell Biol (2012) 1.02

RUbioSeq: a suite of parallelized pipelines to automate exome variation and bisulfite-seq analyses. Bioinformatics (2013) 1.00

Aberrant transcriptional regulations in cancers: genome, transcriptome and epigenome analysis of lung adenocarcinoma cell lines. Nucleic Acids Res (2014) 0.98

MMSET is highly expressed and associated with aggressiveness in neuroblastoma. Cancer Res (2011) 0.93

WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck. Mol Cancer Res (2014) 0.92

WHSC1 links transcription elongation to HIRA-mediated histone H3.3 deposition. EMBO J (2013) 0.89

Mass spectrometric quantification of histone post-translational modifications by a hybrid chemical labeling method. Mol Cell Proteomics (2015) 0.89

Overexpression of MMSET is correlation with poor prognosis in hepatocellular carcinoma. Pathol Oncol Res (2012) 0.83

Overexpression of multiple myeloma SET domain (MMSET) is associated with advanced tumor aggressiveness and poor prognosis in serous ovarian carcinoma. Biomarkers (2013) 0.80

Overexpression of MMSET in endometrial cancer: a clinicopathologic study. J Surg Oncol (2012) 0.79